Elastrin Therapeutics Closes a $10M Funding Round

Funding of $10M was raised by Elastrin Therapeutics, a Greenville-based biotechnology company.

Starbloom Capital, SC Launch and Kizoo Technology Capital participated in the round.

The company plans to use the funds for expansion and development.

Elastrin Therapeutics, a biotech company that develops therapies to reverse heart disease, was established in 2018. It is a spinout company from Clemson University. ELT001 is a EDTA-loaded, nanoparticle that has been conjugated with a proprietary monoclonal anti-vascular calcification antibody.

Get latest news from African Startup ecosystem

Latest stories

You might also like...